首页> 美国卫生研究院文献>Medicina >Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
【2h】

Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review

机译:在创伤后应激障碍(PTSD)中使用药用大麻和合成大麻素:系统评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and Objectives: Post-traumatic stress disorder (PTSD) is a common psychiatric disorder resulting from a traumatic event, is manifested through hyperarousal, anxiety, depressive symptoms, and sleep disturbances. Despite several therapeutic approaches being available, both pharmacological and psychological, recently a growing interest has developed in using cannabis and synthetic cannabinoids stems from their consideration as more efficient and better tolerated alternatives for the treatment of this condition. The present paper aims to evaluate the clinical and therapeutic potentials of medical cannabis and synthetic cannabinoids in treating PTSD patients. Methods: A systematic electronic search was performed, including all papers published up to May 2019, using the following keywords (((cannabis[Title/Abstract]) OR (synthetic cannabinoids [Title/Abstract])) AND ((PTSD[Title/Abstract]) OR (Posttraumatic stress disorder[Title/Abstract]))) for the topics ‘Cannabis’, ‘Synthetic Cannabinoids’, ‘PTSD’, and MESH terms, on the PubMed, Cochrane Library, and Web of Science online databases. For data gathering purposes, PRISMA guidelines were followed. Results were organized into two groups, considering cannabis and synthetic cannabinoids as different therapeutic approaches for PTSD. Results: Present data show that cannabis and synthetic cannabinoids, both acting on the endocannabinoids system, may have a potential therapeutic use for improving PTSD symptoms, e.g., reducing anxiety, modulating memory-related processes, and improving sleep. Conclusions: Even though the current literature suggests that cannabis and synthetic cannabinoids may have a role in the treatment of PTSD, there is currently limited evidence regarding their safety and efficacy. Therefore, additional research is needed in order to better understand the effectiveness and therapeutic usage of these drug classes and monitor their safety.
机译:背景与目的:创伤后应激障碍(PTSD)是由创伤事件引起的常见精神疾病,表现为过度兴奋,焦虑,抑郁症状和睡眠障碍。尽管有几种治疗方法,包括药理学和心理方法,最近人们对使用大麻和合成大麻素的兴趣不断增长,这是由于它们被认为是治疗这种疾病的更有效,耐受性更好的替代品。本文旨在评估医用大麻和合成大麻素在治疗PTSD患者中的临床和治疗潜力。方法:使用以下关键词(((大麻[标题/摘要])或(合成大麻素[标题/摘要]))和((PTSD [标题/摘要])或(创伤后应激障碍[标题/摘要])))在PubMed,Cochrane图书馆和Web of Science在线数据库上,主题为“大麻”,“合成大麻素”,“ PTSD”和MESH术语。为了收集数据,遵循了PRISMA指南。将结果分为两组,将大麻和合成大麻素作为PTSD的不同治疗方法。结果:目前的数据表明,大麻和合成大麻素均作用于内源性大麻素系统,可能具有改善PTSD症状的潜在治疗用途,例如减少焦虑症,调节与记忆有关的过程并改善睡眠。结论:尽管目前的文献表明大麻和合成大麻素可能在PTSD的治疗中起作用,但目前关于其安全性和有效性的证据有限。因此,需要进行更多的研究,以便更好地了解这些药物类别的有效性和治疗用途并监测其安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号